Sherif Monib
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sherif Monib has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
- Emre Pakdemirli
Department of Radiology, Pamukkale University School of Medicine, Denizli, Turkey
6 shared publications Hany Habashy
General Surgery Department, Fayoum University Hospital, Faiyum, Egypt
6 shared publications- Hany F. Habashy
Surgical Oncology, Fayoum University, Faculty of Medicine, Fayoum, EGY
5 shared publications Mohamed Ibrahim
General Surgery Department, Fayoum University Hospital, Faiyum, Egypt
4 shared publicationsAhmed Farghaly
Worcestershire Royal Hospital, NHS Trust
3 shared publications- Mohamed Elkorety
General surgery department, West Hertfordshire Hospitals NHS Trust, St Albans, UK
3 shared publications
Latest Publications
- 7 March 2023
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 14 (3) , 637-643
Iatrogenic Breast Lymphoedema: Incidence, Diagnosis, and Associated Risk Factors
While upper limb lymphoedema following breast and axillary surgery is well established in the literature, breast lymphoedema is rarely documented. Our primary objective was to identify risk factors of breast lymphoedema, and our secondary aim was to assess the possibility of using a breast ultrasound scan to assess breast lymphoedema. This study was a case series analysis, including patients who had wide local excision for primary breast cancer treatment between January 2013 and January 2018. Patients’ demographics, including age, weight, body mass index (BMI), breast volume, tumour characteristics, and histological findings, were noted. All patients had a clinical assessment and ultrasound scan 6 months and 12 months after surgery, comparing ipsilateral to the contralateral breast skin, subcutaneous thickness, as well as parenchymal changes. We have included two hundred eighty-six breast cancer; the mean age was 54.7 years SD 17.3, the mean weight was 76.5 kg SD 12.6, the mean BMI was 31.5 SD 5.2, and the mean breast volume was 1223 ml SD 179. This study identified breast lymphoedema in patients with clinically detected skin oedema in the absence of radiotherapy skin changes; skin and subcutaneous 5 mm added thickness more than the contralateral side, and based on that, 22 patients (7.7%) were found to have breast lymphoedema. We have also found that patients with high BMI, larger breast volume, upper outer quadrant tumours, and patients who had axillary lymph node clearance had an increased incidence of breast lymphoedema. The incidence of breast lymphoedema in this cohort was 7.7%. We suggest that breast lymphoedema should be considered if skin and subcutaneous thickness are 5 mm more than the contralateral side in the absence of severe radiotherapy skin changes. Also, we have found that high body mass index (BMI), larger breast volume, upper outer quadrant tumours, and patients who had axillary lymph node clearance are associated with an increased incidence of breast lymphoedema.
- 7 March 2023
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 14 (3) , 637-643
Iatrogenic Breast Lymphoedema: Incidence, Diagnosis, and Associated Risk Factors
While upper limb lymphoedema following breast and axillary surgery is well established in the literature, breast lymphoedema is rarely documented. Our primary objective was to identify risk factors of breast lymphoedema, and our secondary aim was to assess the possibility of using a breast ultrasound scan to assess breast lymphoedema. This study was a case series analysis, including patients who had wide local excision for primary breast cancer treatment between January 2013 and January 2018. Patients’ demographics, including age, weight, body mass index (BMI), breast volume, tumour characteristics, and histological findings, were noted. All patients had a clinical assessment and ultrasound scan 6 months and 12 months after surgery, comparing ipsilateral to the contralateral breast skin, subcutaneous thickness, as well as parenchymal changes. We have included two hundred eighty-six breast cancer; the mean age was 54.7 years SD 17.3, the mean weight was 76.5 kg SD 12.6, the mean BMI was 31.5 SD 5.2, and the mean breast volume was 1223 ml SD 179. This study identified breast lymphoedema in patients with clinically detected skin oedema in the absence of radiotherapy skin changes; skin and subcutaneous 5 mm added thickness more than the contralateral side, and based on that, 22 patients (7.7%) were found to have breast lymphoedema. We have also found that patients with high BMI, larger breast volume, upper outer quadrant tumours, and patients who had axillary lymph node clearance had an increased incidence of breast lymphoedema. The incidence of breast lymphoedema in this cohort was 7.7%. We suggest that breast lymphoedema should be considered if skin and subcutaneous thickness are 5 mm more than the contralateral side in the absence of severe radiotherapy skin changes. Also, we have found that high body mass index (BMI), larger breast volume, upper outer quadrant tumours, and patients who had axillary lymph node clearance are associated with an increased incidence of breast lymphoedema.
- Open Access
- 8 March 2022
- Vol. 41, 188
Clinical importance of the informed consent process in breast surgery
Breast reconstruction operations have been on the rise over the last two decades; with recent advances in medical practice, different options of breast reconstruction have been readily available. However, it is challenging for patients to grasp the knowledge and digest differences, advantages, and disadvantages of each and every procedure to be able to choose the best procedure for them. Following the Thefaut and Montgomery cases, clinicians are obliged to make sure that all the required information is presented to the patients in a structured manner and suitable environment toaid them in deciding the best procedure for them and guiding them through the informed consent process.
- 8 March 2022
- Vol. 41, 188
Open AccessClinical importance of the informed consent process in breast surgery
Breast reconstruction operations have been on the rise over the last two decades; with recent advances in medical practice, different options of breast reconstruction have been readily available. However, it is challenging for patients to grasp the knowledge and digest differences, advantages, and disadvantages of each and every procedure to be able to choose the best procedure for them. Following the Thefaut and Montgomery cases, clinicians are obliged to make sure that all the required information is presented to the patients in a structured manner and suitable environment toaid them in deciding the best procedure for them and guiding them through the informed consent process.
- Open Access
- 3 November 2021
- Published by Springer Nature in Cureus
- Vol. 13 (11)
Evaluation of the Surgical Outcomes of Breast Oncoplastic Techniques Carried Out by a General Surgical Oncologist
With recent advances in different breast cancer treatment modalities, breast conservation surgery (BCS) has gained popularity and has become the mainstay for the treatment of early breast cancer. The model of dedicated breast surgeons working in breast units is standard in some but not all countries. We have aimed to define surgical outcomes of oncoplastic breast surgery carried out by one general surgical oncologist. We have conducted a prospective non-randomised case series analysis to assess the oncologic and aesthetic outcome of tissue displacement oncoplastic breast techniques in managing unifocal early-stage breast cancer from January 2019 to January 2020. One surgical oncologist with 23 years of surgical oncology experience carried out all operations. We have included 50 female patients treated with variant oncoplastic volume displacement techniques. We have used the round block technique in 20%, the batwing technique in 18%, lateral mammoplasty in 20%, and medial mammoplasty in 2%. We have also carried out wise pattern therapeutic mammoplasty with inferior pedicle in 20% (10 patients), and vertical mammoplasty with superior pedicle in 20% (10 patients). While 8% of our patients had Clavien-Dindo system grade I Immediate complications, including the surgical site infection and postoperative seroma and haematoma, 2% of patients had grade II complications in the form of partial areola and nipple complex necrosis leading to delayed wound healing requiring secondary suturing. No delayed complications or mortalities were recorded. Eight per cent of patients required re-excision to clear margins, 74% had excellent results, 24% had good results, and 2% had fair results. In addition, 64% were very satisfied with their results, 32% were satisfied, while 4% were not satisfied with aesthetic results. Based on our limited number of patients, we have found that tissue displacement oncoplastic techniques carried out by a general surgical oncologist are safe and reliable in providing satisfactory oncological outcomes with a low risk of delaying adjuvant therapy and acceptable aesthetic outcomes.
- 3 November 2021
- Published by Springer Nature in Cureus
- Vol. 13 (11)
Open AccessEvaluation of the Surgical Outcomes of Breast Oncoplastic Techniques Carried Out by a General Surgical Oncologist
With recent advances in different breast cancer treatment modalities, breast conservation surgery (BCS) has gained popularity and has become the mainstay for the treatment of early breast cancer. The model of dedicated breast surgeons working in breast units is standard in some but not all countries. We have aimed to define surgical outcomes of oncoplastic breast surgery carried out by one general surgical oncologist. We have conducted a prospective non-randomised case series analysis to assess the oncologic and aesthetic outcome of tissue displacement oncoplastic breast techniques in managing unifocal early-stage breast cancer from January 2019 to January 2020. One surgical oncologist with 23 years of surgical oncology experience carried out all operations. We have included 50 female patients treated with variant oncoplastic volume displacement techniques. We have used the round block technique in 20%, the batwing technique in 18%, lateral mammoplasty in 20%, and medial mammoplasty in 2%. We have also carried out wise pattern therapeutic mammoplasty with inferior pedicle in 20% (10 patients), and vertical mammoplasty with superior pedicle in 20% (10 patients). While 8% of our patients had Clavien-Dindo system grade I Immediate complications, including the surgical site infection and postoperative seroma and haematoma, 2% of patients had grade II complications in the form of partial areola and nipple complex necrosis leading to delayed wound healing requiring secondary suturing. No delayed complications or mortalities were recorded. Eight per cent of patients required re-excision to clear margins, 74% had excellent results, 24% had good results, and 2% had fair results. In addition, 64% were very satisfied with their results, 32% were satisfied, while 4% were not satisfied with aesthetic results. Based on our limited number of patients, we have found that tissue displacement oncoplastic techniques carried out by a general surgical oncologist are safe and reliable in providing satisfactory oncological outcomes with a low risk of delaying adjuvant therapy and acceptable aesthetic outcomes.
- 6 September 2021
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 12 (4) , 785-791
Adequate Assessment Can Affect the Management of Breast Cancer in Geriatric Population
Breast cancer (BC) risk increases with age; about a third of patients are diagnosed in age older than 65. Treatment of this age group remains controversial, leading to inferior outcomes with lower survival rates than younger patients. We aimed to evaluate performance status tools as well as the outcome of management of breast cancer in the geriatric population. We have conducted a retrospective database analysis looking into the management of breast cancer patients older than 65 years old presenting to our unit during the period between June 2015 and June 2019. All patients had triple assessment as well as multimodality performance status assessment with their treatment modalities, and outcomes are recorded and assessed. We have included 578 patients, 0.8% male and 99.2% female, and our patients’ mean age was 71 years. Most of our patients scored one or two on the WHO/ECOG performance status score and Clinical Frailty Score, as well as ASA-PS score. 3.2% had no treatment, 4.3% had endocrine therapy only, 0.5% had primary endocrine therapy followed by surgery, and 92.3% underwent surgery with 4.1% complication rate. Patients who underwent breast-conserving surgery had adjuvant breast radiotherapy, and 23.7% had adjuvant chest wall radiotherapy, 78.8% had adjuvant endocrine treatment, and 4.8% had adjuvant chemotherapy out of which 30.7% had adjuvant chemotherapy and Herceptin. Objective assessment tools should be used for patients older than 65 years diagnosed with primary breast cancer to be able to scarify patients’ individualised treatment options to reach the optimum outcome.
- 6 September 2021
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 12 (4) , 785-791
Adequate Assessment Can Affect the Management of Breast Cancer in Geriatric Population
Breast cancer (BC) risk increases with age; about a third of patients are diagnosed in age older than 65. Treatment of this age group remains controversial, leading to inferior outcomes with lower survival rates than younger patients. We aimed to evaluate performance status tools as well as the outcome of management of breast cancer in the geriatric population. We have conducted a retrospective database analysis looking into the management of breast cancer patients older than 65 years old presenting to our unit during the period between June 2015 and June 2019. All patients had triple assessment as well as multimodality performance status assessment with their treatment modalities, and outcomes are recorded and assessed. We have included 578 patients, 0.8% male and 99.2% female, and our patients’ mean age was 71 years. Most of our patients scored one or two on the WHO/ECOG performance status score and Clinical Frailty Score, as well as ASA-PS score. 3.2% had no treatment, 4.3% had endocrine therapy only, 0.5% had primary endocrine therapy followed by surgery, and 92.3% underwent surgery with 4.1% complication rate. Patients who underwent breast-conserving surgery had adjuvant breast radiotherapy, and 23.7% had adjuvant chest wall radiotherapy, 78.8% had adjuvant endocrine treatment, and 4.8% had adjuvant chemotherapy out of which 30.7% had adjuvant chemotherapy and Herceptin. Objective assessment tools should be used for patients older than 65 years diagnosed with primary breast cancer to be able to scarify patients’ individualised treatment options to reach the optimum outcome.
- 1 June 2021
- Published by Elsevier in Surgical Oncology
- Vol. 37, 101521
Routine cavity shaves following breast conserving surgery; friend or foe?
- 1 June 2021
- Published by Elsevier in Surgical Oncology
- Vol. 37, 101521
Routine cavity shaves following breast conserving surgery; friend or foe?
- 1 June 2021
- Published by Elsevier in Clinical Breast Cancer
- Vol. 21 (3) , 156-161
Breast Lymphedema After Conservative Breast Surgery: An Up-to-date Systematic Review
- 1 June 2021
- Published by Elsevier in Clinical Breast Cancer
- Vol. 21 (3) , 156-161
Breast Lymphedema After Conservative Breast Surgery: An Up-to-date Systematic Review
- Open Access
- 1 May 2021
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 108 (Supplement)
231 Breast Lymphedema After Breast Conservative Surgery; An Up-To-Date Systematic Review
Background: While arm lymphedema following breast cancer treatment is a common complication; breast lymphedema following treatment is not uncommon. Several risk factors were found to contribute to breast lymphedema, Aim: We aimed to provide a systematic review to help avoiding or management of breast lymphoedema Method: The search term 'breast lymphedema' was combined with 'breast conservative surgery' and was used to conduct literature research in PubMed and Medline. The term lymphedema was combined with breast, conservative and surgery to search Embase database. All papers published in English were included with no exclusion date limits Results: A total of 2155 female patients were included in this review; age ranged from 26 to 90. Mean BMI was 28.4, most of the studies included patients who underwent conservative breast surgery. Incidence of breast lymphedema ranged from 24.8% to 90.4%. Several risk factors were linked to breast lymphedema after conservative breast surgery, such as body mass index (BMI), breast size, tumour size, tumour site, type of surgery and adjuvant therapy. Treatment options focused on decongestive lymphatic therapy, including Manual lymphatic drainage (MLD), self-massaging, compression bras or Kinesio taping. Conclusions: Breast lymphedema is a relatively common complication, yet there is no clear consensus on the definition or treatment options.
- 1 May 2021
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 108 (Supplement)
Open Access231 Breast Lymphedema After Breast Conservative Surgery; An Up-To-Date Systematic Review
Background: While arm lymphedema following breast cancer treatment is a common complication; breast lymphedema following treatment is not uncommon. Several risk factors were found to contribute to breast lymphedema, Aim: We aimed to provide a systematic review to help avoiding or management of breast lymphoedema Method: The search term 'breast lymphedema' was combined with 'breast conservative surgery' and was used to conduct literature research in PubMed and Medline. The term lymphedema was combined with breast, conservative and surgery to search Embase database. All papers published in English were included with no exclusion date limits Results: A total of 2155 female patients were included in this review; age ranged from 26 to 90. Mean BMI was 28.4, most of the studies included patients who underwent conservative breast surgery. Incidence of breast lymphedema ranged from 24.8% to 90.4%. Several risk factors were linked to breast lymphedema after conservative breast surgery, such as body mass index (BMI), breast size, tumour size, tumour site, type of surgery and adjuvant therapy. Treatment options focused on decongestive lymphatic therapy, including Manual lymphatic drainage (MLD), self-massaging, compression bras or Kinesio taping. Conclusions: Breast lymphedema is a relatively common complication, yet there is no clear consensus on the definition or treatment options.
- Open Access
- 27 April 2021
- Published by Springer Nature in Cureus
- Vol. 13 (4)
Giant Lactating Adenoma With Fibroadenomated Changes
Lactating adenomas (LAs) are uncommon benign breast tumors that typically occur in the late pregnancy or lactation period and are among the most prevalent breast lesions during puerperium. They commonly present with a painless, rapidly growing, large, mobile breast lump either late in pregnancy or the postpartum period. Despite being a condition, a core biopsy is almost always required to exclude malignancy. We are presenting a case of a 34-year-old patient who was referred to our unit with a progressive increase in size of the pre-existing right breast lump that has been there before pregnancy. Due to the massive increase in size in a short period, the lump was removed shortly after delivery with an acceptable cosmetic outcome.
- 27 April 2021
- Published by Springer Nature in Cureus
- Vol. 13 (4)
Open AccessGiant Lactating Adenoma With Fibroadenomated Changes
Lactating adenomas (LAs) are uncommon benign breast tumors that typically occur in the late pregnancy or lactation period and are among the most prevalent breast lesions during puerperium. They commonly present with a painless, rapidly growing, large, mobile breast lump either late in pregnancy or the postpartum period. Despite being a condition, a core biopsy is almost always required to exclude malignancy. We are presenting a case of a 34-year-old patient who was referred to our unit with a progressive increase in size of the pre-existing right breast lump that has been there before pregnancy. Due to the massive increase in size in a short period, the lump was removed shortly after delivery with an acceptable cosmetic outcome.
- RetractionOpen Access
- 15 April 2021
- Published by Springer Nature in Cureus
- Vol. 13 (4) , r30
Failure of an Ancient Breast Implant Can Lead to Significant Morbidity
This article has been retracted and removed due to recently discovered issues with the patient consent process. Unbeknownst to the authors at the time patient consent was granted, the patient's next of kin had power-of-attorney and therefore should have been consulted regarding patient consent. As a result, the patient consent form is not valid and the patient now wishes for the article to be removed. The authors have formally requested this retraction.
- 15 April 2021
- Published by Springer Nature in Cureus
- Vol. 13 (4) , r30
RetractionOpen AccessFailure of an Ancient Breast Implant Can Lead to Significant Morbidity
This article has been retracted and removed due to recently discovered issues with the patient consent process. Unbeknownst to the authors at the time patient consent was granted, the patient's next of kin had power-of-attorney and therefore should have been consulted regarding patient consent. As a result, the patient consent form is not valid and the patient now wishes for the article to be removed. The authors have formally requested this retraction.
- Open Access
- 31 March 2021
- Published by Springer Nature in Cureus
- Vol. 13 (3)
Breast Cancer in the Presence of Failed Saline Breast Implants
Breast augmentation has been gaining popularity over the last two decades to correct congenital breast asymmetry or increase breast size and projection. Augmentation options started with saline implants, then silicone implants, and, recently, autologous fat transfer. Unfortunately, breast implants are not without complications, some of which are common, like capsular contracture, implant failure and infection. Others are quite rare, such as Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Most of these complications will eventually require explantation in most cases, as the patients’ and implants' age and risk of complications increase. We present a 79-year-old patient who presented to our breast unit with a left breast lump with 50-year-old saline implants. A triple assessment revealed incidental right breast cancer treated with radiofrequency identification (RFID) tag-guided wide local excision, sentinel lymph node biopsy and bilateral explantation.
- 31 March 2021
- Published by Springer Nature in Cureus
- Vol. 13 (3)
Open AccessBreast Cancer in the Presence of Failed Saline Breast Implants
Breast augmentation has been gaining popularity over the last two decades to correct congenital breast asymmetry or increase breast size and projection. Augmentation options started with saline implants, then silicone implants, and, recently, autologous fat transfer. Unfortunately, breast implants are not without complications, some of which are common, like capsular contracture, implant failure and infection. Others are quite rare, such as Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Most of these complications will eventually require explantation in most cases, as the patients’ and implants' age and risk of complications increase. We present a 79-year-old patient who presented to our breast unit with a left breast lump with 50-year-old saline implants. A triple assessment revealed incidental right breast cancer treated with radiofrequency identification (RFID) tag-guided wide local excision, sentinel lymph node biopsy and bilateral explantation.